Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-025433

Chief Commercial Officer, SaaS sold 4,260 shares at $238.48 ($1,015,925)

  • Chief Commercial Officer, SaaS acquired 4,260 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ghoshal Kaushik · Chief Commercial Officer, SaaS

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-11 Exercise or conversion : show line 1 in the form 10b5-1 +4,260 $101.64 $432,986 26,048 D
2024-10-11 Sale : show line 2 in the form 10b5-1 −4,260 $238.48 $1,015,925 21,788 D
Open-market sales · 4,260 sh · avg $238.48 · $1,015,925

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-11 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −4,260 0 D
Loading xslF345X05/form4.xml…